‘Skinny labels’ on generics can save patients money, research shows, but recent court decisions cloud future
New research shows how generic drug companies can successfully market a limited number of approved indications for a brand name drug, prior to coming to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
